Table 2.

The relationship between BOLA family members and OS in other different subtypes of OC (Kaplan-Meier plotter)

Subtypes		BOLA1			BOLA2			BOLA3
		Cases	HR (95% CI)	P value	Cases	HR (95% CI)	P value	Cases	HR (95% CI)	Pvalue
Histology	Serous	1207	0.93(0.8–1.08)	0.34	1207	0.86(0.73–1.01)	0.061	523	1.36(1.04–1.77)	0.022
	Endometrioid	37	2.13(0.24–19.05)	0.49	37	4.42(0.74–26.51)	0.075	30	3.77(0.39–36.42)	0.22
Stage	1	74	2.29 (0.73–7.25)	0.15	74	0.43 (0.14–1.35)	0.14	51	2.52 (0.6–10.55)	0.19
	2	61	0.52 (0.18–1.5)	0.22	61	0.28 (0.08–1.01)	0.038	32	0.16 (0.02–1.36)	0.057
	3	1044	1.15 (0.97–1.36)	0.097	1044	1.15 (0.95–1.38)	0.15	426	1.38 (1.05–1.81)	0.019
	4	176	1.38 (0.95–2.01)	0.087	176	0.69 (0.47–1.02)	0.059	61	0.49 (0.26–0.9)	0.019
Grade	1 + 2	380	1.54 (1.16–2.06)	0.003	380	0.79 (0.6–1.06)	0.11	203	1.54 (0.97–2.46)	0.064
	3	1015	1.11 (0.92–1.34)	0.28	1015	0.82 (0.7–0.98)	0.025	392	0.73 (0.56–0.96)	0.022
TP53	Mutated	506	0.84 (0.65–1.08)	0.17	506	0.71 (0.56–0.89)	0.0025	124	0.79 (0.54–1.16)	0.23
	WT	94	0.5 (0.29–0.89)	0.015	94	0.54 (0.25–1.14)	0.1	19	1.38 (0.49–3.92)	0.54
CR	Platin	1409	1.14 (0.99–1.32)	0.07	1409	0.94 (0.81–1.09)	0.41	478	1.30 (1–1.69)	0.047
	Taxol	793	1.16 (0.95–1.4)	0.14	793	1.17 (0.97–1.41)	0.11	357	1.39 (1.01–1.93)	0.043
	Taxol + platin	776	1.17 (0.97–1.43)	0.10	776	1.19 (0.98–1.44)	0.075	356	1.40(1.01–1.93)	0.041

The bold font indicates the difference was significant statistically

OC ovarian cancer, OS overall survival, WT wild type, CR Chemotherapy Regimen